Search

Your search keyword '"Maher, M.M."' showing total 5 results
Start Over Author "Maher, M.M." Search Limiters Full Text
5 results on '"Maher, M.M."'

2. Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI)

Author

Caplice, N.M., DeVoe, M.C., Choi, J., Dahly, D., Murphy, T., Spitzer, E., Geuns, R.J.M. van, Maher, M.M., Tuite, D., Kerins, D.M., Ali, M.T., Kalyar, I., Fahy, E.F., Khider, W., Kelly, P., Kearney, P.P., Curtin, R.J., O'Shea, C., Vaughan, C.J., Eustace, J.A., McFadden, E.P., Caplice, N.M., DeVoe, M.C., Choi, J., Dahly, D., Murphy, T., Spitzer, E., Geuns, R.J.M. van, Maher, M.M., Tuite, D., Kerins, D.M., Ali, M.T., Kalyar, I., Fahy, E.F., Khider, W., Kelly, P., Kearney, P.P., Curtin, R.J., O'Shea, C., Vaughan, C.J., Eustace, J.A., and McFadden, E.P.

Abstract

Item does not contain fulltext, BACKGROUND: Residual and significant postinfarction left ventricular (LV) dysfunction, despite technically successful percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI), remains an important clinical issue. In preclinical models, low-dose insulin-like growth factor 1 (IGF1) has potent cytoprotective and positive cardiac remodeling effects. We studied the safety and efficacy of immediate post-PCI low-dose intracoronary IGF1 infusion in STEMI patients. METHODS: Using a double-blind, placebo-controlled, multidose study design, we randomized 47 STEMI patients with significantly reduced (

Published
2018

4. 232 Lumacaftor/Ivacaftor is associated with a significant improvement in walk test and reduction in sweat chloride in a cohort of homozygous F508del CF patients with severe disease – a single centre experience

Author

Ronan, N.J., primary, McCarthy, Y., additional, James, K., additional, Arooj, P., additional, Hunt, E.B., additional, Shortt, C., additional, Fleming, C., additional, McCarthy, M., additional, Howlett, C., additional, Hickey, C., additional, Flanagan, E., additional, Daly, M., additional, Eustace, J.A., additional, Maher, M.M., additional, and Plant, B.J., additional

Published
2017
Full Text
View/download PDF

5. WS20.4 Clinical outcomes of Real-World Kalydeco (CORK) study – a prospective 12 month analysis addressing the impact of CFTR modulation on the cystic fibrosis lung

Author

Ronan, N.J., primary, O'Callaghan, G.P., additional, Mooney, D., additional, Einarsson, G., additional, Elborn, J.S., additional, Ni Chroinin, M., additional, Mullane, D., additional, Murphy, D.M., additional, O'Connor, O.J., additional, Shortt, C., additional, Tunney, M.M., additional, Twomey, M., additional, Maher, M.M., additional, Eustace, J.A., additional, and Plant, B.J., additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results